Inlyta (Axitinib) tablets


Medical EvidenceInlyta

Generic name : Axitinib.

Trade name : Inlyta.

Manufacturer information :

Inlyta is manufactured by Pfizer Inc.

Inlyta FDA Approval :

Inlyta first approved January 27th, 2012.

Inlyta Dosage form :

1 mg and 5 mg tablets.

Inlyta Indications and Usage :

Renal Cell Carcinoma

Indicated for treatment of advanced renal cell carcinoma after failure of 1 prior systemic therapy.

Inlyta (Axitinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.